Chad Hamilton to Paclitaxel
This is a "connection" page, showing publications Chad Hamilton has written about Paclitaxel.
Connection Strength
0.459
-
Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line. Hum Cell. 2017 Jul; 30(3):226-236.
Score: 0.129
-
Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patients. J Proteome Res. 2015 Apr 03; 14(4):1900-10.
Score: 0.113
-
The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group study. Gynecol Oncol. 2011 Sep; 122(3):521-6.
Score: 0.087
-
Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys. 2005 Nov 01; 63(3):839-44.
Score: 0.059
-
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma. Obstet Gynecol. 2019 02; 133(2):245-254.
Score: 0.037
-
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2018 06; 149(3):525-530.
Score: 0.035